Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 689-166-9 | N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide | 1195765-45-7 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Repr. 2 | H361fd | H361fd |
GHS08 GHS09 Wng |
State/Form
|
6 |  |
View details | ||||
| STOT RE 2 | H373 (other:multiple ...) (oral) | H373 | |||||||||
| Aquatic Acute 1 | H400 | H400 | |||||||||
| Aquatic Chronic 2 | H411 | H411 | |||||||||
| Repr. 2 | H361 (Effect on mater...) | H361 |
GHS08 GHS09 Wng |
State/Form
|
1 | |
View details | ||||
| Aquatic Acute 1 | H400 | H400 | |||||||||
| Aquatic Chronic 2 | H411 | H411 | |||||||||
| Repr. 2 | H361 (fd) | H361 (fd) |
Wng |
State/Form
|
1 | View details | |||||
| STOT RE 2 | H373 (heart) | H373 (heart) | |||||||||
| Aquatic Acute 1 | H400 | H400 | |||||||||
| Aquatic Chronic 2 | H411 | H411 | |||||||||
Number of Aggregated Notifications: 3